Faron Pharmaceuticals Oy
FARN.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £0 | £219 | £78 | £241 |
| - Cash | £14 | £10 | £30 | £7 |
| + Debt | £22 | £12 | £13 | £13 |
| Enterprise Value | £9 | £222 | £60 | £247 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | – | – | – | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | – | – | – | – |
| EBITDA | -£0 | -£0 | -£0 | -£0 |
| % Margin | – | – | – | – |
| Net Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.09 | -0.054 | -0.1 | -0.13 |
| % Growth | -67.1% | 45.9% | 23.1% | – |
| Operating Cash Flow | -£0 | -£0 | -£0 | -£0 |
| Capital Expenditures | £0 | £0 | £0 | £0 |
| Free Cash Flow | -£0 | -£0 | -£0 | -£0 |